KDM4E
MOLECULAR TARGETlysine demethylase 4E
KDM4E (lysine demethylase 4E) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KDM4E
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | trichostatin | 5.45 | 232 |
| 2 | dopamine | 5.45 | 231 |
| 3 | lapachone | 4.34 | 76 |
| 4 | fenoldopam | 2.71 | 14 |
| 5 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 1.10 | 2 |
| 6 | Methyldopa | 0.69 | 1 |
About KDM4E as a Drug Target
KDM4E (lysine demethylase 4E) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented KDM4E interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KDM4E inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.